Literature DB >> 1736570

Use of rapid serial sampling of creatine kinase MB for very early detection of myocardial infarction in patients with acute chest pain.

M M Marin1, S L Teichman.   

Abstract

To determine how early myocardial infarction can be detected, serial creatine kinase MB concentrations were sampled in 313 patients during triage of acute (less than 12 hours) chest pain. Serum was sampled on hospital arrival (baseline) and hourly for 3 hours (total of four samples). Creatine kinase MB concentrations were subsequently analyzed for their ability to detect infarction. Infarction was present in 70 patients (22%) and was diagnosable from the index electrocardiograms in 27 of these (39%). Sensitivity and specificity for detection of infarction were 76% and 72%, respectively, as determined from baseline MB values only and increased with each additional sample to a maximum of 92% and 96%, respectively, in all four samples. Analysis of two serum samples taken 2 hours apart showed a sensitivity of 94% and a specificity of 91%. If these results are confirmed, improved initial diagnostic accuracy with this rapid assay technique in acute chest pain may (1) conserve resources when initial suspicion of infarction is low, (2) identify patients with infarction appropriate for early intervention, and (3) avoid premature hospital discharge of patients with infarction.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1736570     DOI: 10.1016/0002-8703(92)90646-d

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  7 in total

Review 1.  The role of CK-MB in chest pain decision-making.

Authors:  J R Hedges
Journal:  J Accid Emerg Med       Date:  1995-06

2.  Will serum enzymes and other proteins find a clinical application in the early diagnosis of myocardial infarction?

Authors:  I Gunn; D Matthews; I O'Brien
Journal:  Br Heart J       Date:  1995-01

3.  Will serum enzymes and other proteins find a clinical application in the early diagnosis of myocardial infarction?

Authors:  A D Timmis
Journal:  Br Heart J       Date:  1994-04

4.  Deciding who needs thrombolysis. Validation of ECG diagnosis inadequate.

Authors:  O M Jolobe
Journal:  BMJ       Date:  1993-09-25

5.  Comparison of the value of novel rapid measurement of myoglobin, creatine kinase, and creatine kinase-MB with the electrocardiogram for the diagnosis of acute myocardial infarction.

Authors:  H S Lee; S J Cross; P Garthwaite; A Dickie; I Ross; S Walton; K Jennings
Journal:  Br Heart J       Date:  1994-04

Review 6.  Critical pathways for patients with acute chest pain at low risk.

Authors:  Kirsten E Fleischmann; Lee Goldman; Paula A Johnson; Richard A Krasuski; J Stephen Bohan; L Howard Hartley; Thomas H Lee
Journal:  J Thromb Thrombolysis       Date:  2002-04       Impact factor: 2.300

Review 7.  Nanoscale Technologies for Prevention and Treatment of Heart Failure: Challenges and Opportunities.

Authors:  Mohammad Javad Hajipour; Mehdi Mehrani; Seyed Hesameddin Abbasi; Ahmad Amin; Seyed Ebrahim Kassaian; Jessica C Garbern; Giulio Caracciolo; Steven Zanganeh; Mitra Chitsazan; Haniyeh Aghaverdi; Seyed Mehdi Kamali Shahri; Aliakbar Ashkarran; Mohammad Raoufi; Holly Bauser-Heaton; Jianyi Zhang; Jochen D Muehlschlegel; Anna Moore; Richard T Lee; Joseph C Wu; Vahid Serpooshan; Morteza Mahmoudi
Journal:  Chem Rev       Date:  2019-09-06       Impact factor: 60.622

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.